The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

被引:0
作者
Nicole Stopa
Jocelyn E. Krebs
David Shechter
机构
[1] University of Alaska Anchorage,Department of Biological Sciences
[2] Albert Einstein College of Medicine of Yeshiva University,Department of Biochemistry
来源
Cellular and Molecular Life Sciences | 2015年 / 72卷
关键词
Protein arginine methyltransferase; Histones; Spliceosome; Development; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Post-translational arginine methylation is responsible for regulation of many biological processes. The protein arginine methyltransferase 5 (PRMT5, also known as Hsl7, Jbp1, Skb1, Capsuleen, or Dart5) is the major enzyme responsible for mono- and symmetric dimethylation of arginine. An expanding literature demonstrates its critical biological function in a wide range of cellular processes. Histone and other protein methylation by PRMT5 regulate genome organization, transcription, stem cells, primordial germ cells, differentiation, the cell cycle, and spliceosome assembly. Metazoan PRMT5 is found in complex with the WD-repeat protein MEP50 (also known as Wdr77, androgen receptor coactivator p44, or Valois). PRMT5 also directly associates with a range of other protein factors, including pICln, Menin, CoPR5 and RioK1 that may alter its subcellular localization and protein substrate selection. Protein substrate and PRMT5–MEP50 post-translation modifications induce crosstalk to regulate PRMT5 activity. Crystal structures of C. elegans PRMT5 and human and frog PRMT5–MEP50 complexes provide substantial insight into the mechanisms of substrate recognition and procession to dimethylation. Enzymological studies of PRMT5 have uncovered compelling insights essential for future development of specific PRMT5 inhibitors. In addition, newly accumulating evidence implicates PRMT5 and MEP50 expression levels and their methyltransferase activity in cancer tumorigenesis, and, significantly, as markers of poor clinical outcome, marking them as potential oncogenes. Here, we review the substantial new literature on PRMT5 and its partners to highlight the significance of understanding this essential enzyme in health and disease.
引用
收藏
页码:2041 / 2059
页数:18
相关论文
共 1325 条
  • [1] Di Lorenzo A(2011)Histone arginine methylation FEBS Lett 585 2024-2031
  • [2] Bedford MT(1999)S-Adenosylmethionine-dependent methylation in J Biol Chem 274 814-824
  • [3] Niewmierzycka A(2009). Identification of a novel protein arginine methyltransferase Mol Cell 33 1-13
  • [4] Clarke S(2012)Protein arginine methylation in mammals: who, what, and why Nat Struct Mol Biol 19 136-144
  • [5] Bedford MT(2012)Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance J Biol Chem 287 7859-7870
  • [6] Clarke SG(2013)Human protein arginine methyltransferase 7 (PRMT7) is a type III enzyme forming omega-NG-monomethylated arginine residues J Biol Chem 288 37010-37025
  • [7] Migliori V(2014)Mammalian protein arginine methyltransferase 7 (PRMT7) specifically targets RXR sites in lysine- and arginine-rich regions Nature 509 575-581
  • [8] Muller J(2006)A draft map of the human proteome Biochem Biophys Res Commun 342 472-481
  • [9] Phalke S(1996)FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues Genes Dev 10 1327-1340
  • [10] Low D(1998)A search for proteins that interact genetically with histone H3 and H4 amino termini uncovers novel regulators of the Swe1 kinase in Proc Natl Acad Sci USA 95 14781-14786